449 Results

People

  1. Wolchok
    Wolchok
  2. Postow
    Postow
  3. Motzer
    Motzer
  4. Callahan
    Callahan
  5. Shoushtari
    Shoushtari
  6. Allison
    Allison
  7. Panageas
    Panageas
  8. Hellmann
    Hellmann
  9. Slovin
    Slovin
  10. Chapman
    Chapman

Groups

  1. Department of Medicine (349)
  2. Solid Tumor Oncology Division (318)
  3. Melanoma and Immunotherapeutics Service (170)
  4. GSK Faculty (141)
  5. Melanoma Disease Management Team (130)
  6. Hematologic Malignancies, Division of (92)
  7. Genitourinary Oncology Service (84)
  8. Surgery (58)
  9. Weinberg Fellows (50)
  10. Sloan Kettering Institute Postdocs (43)
  1. "ipilimumab"
Formats
  1. Journal Article (349)
  2. Review (61)
  3. Editorial (17)
  4. Guidelines (5)
  5. Meeting Abstract (5)
  6. Research Letter (5)
  7. Book Section (4)
  8. Correspondence (2)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (349)
  2. Solid Tumor Oncology Division (318)
  3. Melanoma and Immunotherapeutics Service (170)
  4. GSK Faculty (141)
  5. Melanoma Disease Management Team (130)
  6. Hematologic Malignancies, Division of (92)

More Groups

People
  1. Jedd Wolchok (104)
  2. Michael Postow (73)
  3. Margaret Callahan (39)
  4. Robert Motzer (31)
  5. Alexander Shoushtari (28)
  6. Paul Chapman (23)

More People

Years
  1. 2025 (21)
  2. 2024 (44)
  3. 2023 (44)
  4. 2022 (33)
  5. 2021 (26)
  6. 2020 (43)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Clinical Cancer Research (21)
  3. Journal for ImmunoTherapy of Cancer (20)
  4. Lancet Oncology (17)
  5. Annals of Oncology (15)
  6. European Journal of Cancer (15)

More Publications

Publishers
  1. Elsevier Inc. (65)
  2. Elsevier Science, Inc. (36)
  3. American Association for Cancer Research (31)
  4. Oxford University Press (28)
  5. American Society of Clinical Oncology (25)
  6. Wiley Blackwell (24)

More Publishers

Results (449)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden
    Journal Article

    Hellmann, M. D.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Otterson, G. A.; Audigier-Valette, C.; Minenza, E.; Linardou, H.; Burgers, S.; Salman, P.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Changing the standard of care for treating melanoma brain metastases
    Journal Article

    Chapman, P. B.
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • ESCMID Study Group for Infections in Compromised Hosts (ESGICH) consensus document on the safety of targeted and biological therapies: An infectious diseases perspective (immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)
    Journal Article

    Redelman-Sidi, G.; Michielin, O.; Cervera, C.; Ribi, C.; Aguado, J. M.; Fernández-Ruiz, M.; Manuel, O.
    Clinical Microbiology and Infection (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors
    Journal Article

    Martin, M.; Sabari, J. K.; Turashvili, G.; Halpenny, D. F.; Rizvi, H.; Shapnik, N.; Makker, V.
    Gynecologic Oncology Reports (2018)

    Fulltext@MSK | Save
  • Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer
    Journal Article

    Hellmann, M. D.; Callahan, M. K.; Awad, M. M.; Calvo, E.; Ascierto, P. A.; Atmaca, A.; Rizvi, N. A.; Hirsch, F. R.; Selvaggi, G.; Szustakowski, J. D.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Myocarditis in patients treated with immune checkpoint inhibitors
    Journal Article

    Mahmood, S. S.; Fradley, M. G.; Cohen, J. V.; Nohria, A.; Reynolds, K. L.; Heinzerling, L. M.; Sullivan, R. J.; Damrongwatanasuk, R.; Chen, C. L.; Gupta, D.; more...
    Journal of the American College of Cardiology (2018)

    Fulltext@MSK | Save
  • Perioperative immunotherapy in muscle-invasive bladder cancer and upper tract urothelial carcinoma
    Journal Article

    Teo, M. Y.; Rosenberg, J. E.
    Urologic Clinics of North America (2018)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Tannir, N. M.; McDermott, D. F.; Arén Frontera, O.; Melichar, B.; Choueiri, T. K.; Plimack, E. R.; Barthélémy, P.; Porta, C.; George, S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: Results from exploratory phase I cohorts of CheckMate 143
    Journal Article

    Omuro, A.; Vlahovic, G.; Lim, M.; Sahebjam, S.; Baehring, J.; Cloughesy, T.; Voloschin, A.; Ramkissoon, S. H.; Ligon, K. L.; Latek, R.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save